Abilify when does it go generic

There are thirty-one patents protecting this drug. This drug has six hundred and sixty-seven patent family members in forty-one countries. There are forty-nine drug master file entries for this compound.

Forty-four suppliers are listed for this compound. Additional details are available on the aripiprazole profile page. Free Forever Trial. Subscribe to access the full database , or Free Forever Trial.

Serving leading biopharmaceutical companies globally:. Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.

The data presented herein is for information purposes only. Related: First atypical antipsychotic approved for pediatric patients with bipolar I disorder in five years. All atypical antipsychotics contain a Boxed Warning alerting healthcare professionals about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia-related psychosis.

No drug in this class is approved to treat patients with dementia-related psychosis. Read next: Cholesterol-lowering agent leads list of most-prescribed drugs. Patients should be monitored for worsening and emergence of suicidal thoughts and behaviors.

In the clinical trials for Abilify, the most common side effects reported by adults taking Abilify were nausea, vomiting, constipation, headache, dizziness, uncontrollable limb and body movements akathisia , anxiety, insomnia, and restlessness.